HR. 4434In Committee
Cosmetic Supply Chain Transparency Act of 2025
Require FDA to track harmful nonfunctional constituents in cosmetics and impose testing disclosure and recordkeeping rules across the cosmetic supply chain
Plain-English overview
What this bill does
Require FDA to track harmful nonfunctional constituents in cosmetics and impose testing disclosure and recordkeeping rules across the cosmetic supply chain
Key points
- Require FDA constituent list
- Require supplier constituent testing
- Direct FDA industry guidance
- Impose civil penalties
Current status
Where it stands
Status
In Committee
Latest action
2025-07-16 — Referred to the House Committee on Energy and Commerce.
Related context
Topics and policy areas
undefinedHealth